- Home
- PTNM vs CRVS Comparison
PTNM vs CRVS Comparison
Compare PTNM & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTNM
- CRVS
- Stock Information
- Founded
- PTNM 2013
- CRVS 2014
- Country
- PTNM Hong Kong
- CRVS United States
- Employees
- PTNM N/A
- CRVS N/A
- Industry
- PTNM
- CRVS Biotechnology: Pharmaceutical Preparations
- Sector
- PTNM
- CRVS Health Care
- Exchange
- PTNM Nasdaq
- CRVS Nasdaq
- Market Cap
- PTNM 320.2M
- CRVS 305.4M
- IPO Year
- PTNM 2025
- CRVS 2016
- Fundamental
- Price
- PTNM $1.85
- CRVS $5.75
- Analyst Decision
- PTNM
- CRVS Strong Buy
- Analyst Count
- PTNM 0
- CRVS 4
- Target Price
- PTNM N/A
- CRVS $15.00
- AVG Volume (30 Days)
- PTNM 3.3M
- CRVS 494.0K
- Earning Date
- PTNM 01-01-0001
- CRVS 08-07-2025
- Dividend Yield
- PTNM N/A
- CRVS N/A
- EPS Growth
- PTNM N/A
- CRVS N/A
- EPS
- PTNM 0.05
- CRVS N/A
- Revenue
- PTNM $9,644,233.00
- CRVS N/A
- Revenue This Year
- PTNM N/A
- CRVS N/A
- Revenue Next Year
- PTNM N/A
- CRVS N/A
- P/E Ratio
- PTNM $39.06
- CRVS N/A
- Revenue Growth
- PTNM 9.87
- CRVS N/A
- 52 Week Low
- PTNM $0.98
- CRVS $2.54
- 52 Week High
- PTNM $14.79
- CRVS $10.00
- Technical
- Relative Strength Index (RSI)
- PTNM N/A
- CRVS 65.10
- Support Level
- PTNM N/A
- CRVS $5.28
- Resistance Level
- PTNM N/A
- CRVS $5.64
- Average True Range (ATR)
- PTNM 0.00
- CRVS 0.30
- MACD
- PTNM 0.00
- CRVS 0.03
- Stochastic Oscillator
- PTNM 0.00
- CRVS 77.70
About PTNM Pitanium Limited Class A Ordinary shares
Pitanium Ltd is a retailer in Hong Kong focusing on the sale of its proprietary brand of skincare and personal care products, especially haircare products, namely PITANIUM and BIG PI online and offline with six retail stores situated in Prime shopping destinations in Hong Kong. The company emphasizes product design and development with an in-house product development team working closely with its original equipment manufacturing (OEM) and original design manufacturing (ODM) suppliers.
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).